Company / FCF Margin
KIORA PHARMACEUTICALS INC FCF Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
53.4%
FY2025
5-year range
-60844.6% / 53.4%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 6 years, ranging from -60844.6% in FY2021 to 53.4% in FY2025.
Based on SEC 10-K filings.
53.4% in FY2025 with a 5-year CAGR of +357.0%.
Improved from -303.6% to 53.4% over the past 5 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +357.0pp
- 10-Year Change
- -
Key checks
Key Insights
- Lowest fcf margin in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 53.4% | - |
| FY2024 | - | - |
| FY2021 | -60844.6% | -19943.0% |
| FY2020 | -303.6% | +53.8% |
| FY2019 | -657.4% | +58.8% |
| FY2018 | -1596.4% | -27.0% |
| FY2017 | -1257.1% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026